Filing Details

Accession Number:
0001209191-20-065303
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-28 21:35:46
Reporting Period:
2020-12-22
Accepted Time:
2020-12-28 21:35:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661998 Homology Medicines Inc. FIXX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219014 M Scott Rocklage 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1240357 D John Diekman 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1589314 5Am Partners Iv, Llc 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1589315 5Am Ventures Iv, L.p. 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1593361 5Am Co-Investors Iv, L.p. 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1598549 J. Andrew Schwab 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-22 480,000 $12.82 4,354,484 No 4 S Indirect See footnote
Common Stock Disposition 2020-12-22 20,000 $12.82 181,435 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. The shares are held by 5AM Ventures IV, L.P. ("Ventures IV"). 5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage, are the managing members of Partners IV, and have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.
  2. The shares are held by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage, are the managing members of Partners IV, and have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.